128 related articles for article (PubMed ID: 10052992)
1. A novel protein cross-linking reaction in stressed Neutral Protamine Hagedorn formulations of insulin.
Beavis RC; Kneirman MD; Sharknas D; Heady MA; Frank BH; DeFelippis MR
J Pharm Sci; 1999 Mar; 88(3):331-6. PubMed ID: 10052992
[TBL] [Abstract][Full Text] [Related]
2. Preparation and characterization of a cocrystalline suspension of [LysB28,ProB29]-human insulin analogue.
DeFelippis MR; Bakaysa DL; Bell MA; Heady MA; Li S; Pye S; Youngman KM; Radziuk J; Frank BH
J Pharm Sci; 1998 Feb; 87(2):170-6. PubMed ID: 9519149
[TBL] [Abstract][Full Text] [Related]
3. Structural characterization of insulin NPH formulations.
Norrman M; Hubálek F; Schluckebier G
Eur J Pharm Sci; 2007 Apr; 30(5):414-23. PubMed ID: 17339105
[TBL] [Abstract][Full Text] [Related]
4. Plain and mono-pegylated recombinant human insulin exhibit similar stress-induced aggregation profiles.
Torosantucci R; Kukrer B; Mero A; Van Winsen M; Tantipolphan R; Jiskoot W
J Pharm Sci; 2011 Jul; 100(7):2574-85. PubMed ID: 21344414
[TBL] [Abstract][Full Text] [Related]
5. Structural studies of a crystalline insulin analog complex with protamine by atomic force microscopy.
Yip CM; Brader ML; Frank BH; DeFelippis MR; Ward MD
Biophys J; 2000 Jan; 78(1):466-73. PubMed ID: 10620310
[TBL] [Abstract][Full Text] [Related]
6. Analysis of protamine peptides in insulin pharmaceutical formulations by capillary electrophoresis.
Lamalle C; Servais AC; Demelenne A; Crommen J; Fillet M
J Sep Sci; 2016 Mar; 39(6):1189-94. PubMed ID: 26829340
[TBL] [Abstract][Full Text] [Related]
7. Chemical cross-linking with NHS esters: a systematic study on amino acid reactivities.
Mädler S; Bich C; Touboul D; Zenobi R
J Mass Spectrom; 2009 May; 44(5):694-706. PubMed ID: 19132714
[TBL] [Abstract][Full Text] [Related]
8. Novel inter-protein cross-link identified in the GGH-ecotin D137Y dimer.
Person MD; Brown KC; Mahrus S; Craik CS; Burlingame AL
Protein Sci; 2001 Aug; 10(8):1549-62. PubMed ID: 11468352
[TBL] [Abstract][Full Text] [Related]
9. Reversible adsorption of soluble hexameric insulin onto the surface of insulin crystals cocrystallized with protamine: an electrostatic interaction.
Dodd SW; Havel HA; Kovach PM; Lakshminarayan C; Redmon MP; Sargeant CM; Sullivan GR; Beals JM
Pharm Res; 1995 Jan; 12(1):60-8. PubMed ID: 7724489
[TBL] [Abstract][Full Text] [Related]
10. PEG-modified protamine with improved pharmacological/pharmaceutical properties as a potential protamine substitute: synthesis and in vitro evaluation.
Chang LC; Lee HF; Chung MJ; Yang VC
Bioconjug Chem; 2005; 16(1):147-55. PubMed ID: 15656586
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and cross-linking activities of oligodeoxynucleotides containing a 4-oxoalkenal group.
Kobori A; Kobuchi T; Ikeda M; Murakami A
Nucleic Acids Symp Ser (Oxf); 2006; (50):59-60. PubMed ID: 17150816
[TBL] [Abstract][Full Text] [Related]
12. The use of low molecular weight protamine chemical chimera to enhance monomeric insulin intestinal absorption.
He H; Sheng J; David AE; Kwon YM; Zhang J; Huang Y; Wang J; Yang VC
Biomaterials; 2013 Oct; 34(31):7733-43. PubMed ID: 23863452
[TBL] [Abstract][Full Text] [Related]
13. Low molecular weight protamine (LMWP): a nontoxic protamine substitute and an effective cell-penetrating peptide.
He H; Ye J; Liu E; Liang Q; Liu Q; Yang VC
J Control Release; 2014 Nov; 193():63-73. PubMed ID: 24943246
[TBL] [Abstract][Full Text] [Related]
14. Simultaneous characterization of insulin HMWP and protamine sulphate in complex formulations through SEC-coupled mass spectrometry.
Srivatsa K; Gokhale Y; Chakrabarti PP; Kulshrestha A; Vajpai N
J Pharm Biomed Anal; 2021 Sep; 203():114188. PubMed ID: 34126389
[TBL] [Abstract][Full Text] [Related]
15. Chemical stability of insulin. 5. Isolation, characterization and identification of insulin transformation products.
Brange J; Hallund O; Sørensen E
Acta Pharm Nord; 1992; 4(4):223-32. PubMed ID: 1294187
[TBL] [Abstract][Full Text] [Related]
16. Keratin films from chicken feathers for controlled drug release.
Li FY; Wang RM; He YF; Li XX; Song PF; Ying XC; Mao CW
J Control Release; 2011 Nov; 152 Suppl 1():e92-3. PubMed ID: 22195951
[No Abstract] [Full Text] [Related]
17. Anaphylaxis to subcutaneous neutral protamine Hagedorn insulin with simultaneous sensitization to protamine and insulin.
Blanco C; Castillo R; Quiralte J; Delgado J; García I; de Pablos P; Carrillo T
Allergy; 1996 Jun; 51(6):421-4. PubMed ID: 8837667
[TBL] [Abstract][Full Text] [Related]
18. An assay combining high-performance liquid chromatography and mass spectrometry to measure DNA interstrand cross-linking efficiency in oligonucleotides of varying sequences.
Narayanaswamy M; Griffiths WJ; Howard PW; Thurston DE
Anal Biochem; 2008 Mar; 374(1):173-81. PubMed ID: 18082123
[TBL] [Abstract][Full Text] [Related]
19. Delayed-type hypersensitivity to protamine as a complication of insulin therapy.
Raap U; Liekenbröcker T; Kapp A; Wedi B
Contact Dermatitis; 2005 Jul; 53(1):57-8. PubMed ID: 15982236
[No Abstract] [Full Text] [Related]
20. Evaluation of patients at risk for protamine reactions.
Levy JH; Schwieger IM; Zaidan JR; Faraj BA; Weintraub WS
J Thorac Cardiovasc Surg; 1989 Aug; 98(2):200-4. PubMed ID: 2755152
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
